Ledger.Open graph →
SEC Form D · filed November 2, 2018

Stoke Therapeutics, Inc

Offering
$90.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Bedford, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Seth L. Harrison · Bedford, MADirectorBarry M. Ticho · Bedford, MAExecCharles R. Allerson · Bedford, MAExecGene M. Liau · Bedford, MAExecAdrian R. Krainer · Bedford, MAExec · Director · PromoterEdward M. Kaye · Bedford, MAExec · DirectorSamuel W. Hall · Bedford, MADirectorMeena R. Meena · Bedford, MAExecArthur A. Levin · Bedford, MADirectorArthur W. Tzianabos · Bedford, MADirectorIsabel M. Aznarez · Bedford, MAExec · PromoterHuw M. Nash · Bedford, MAExecBarry M. Ticho · Bedford, MAExecCharles R. Allerson · Bedford, MAExecGene M. Liau · Bedford, MAExecAdrian R. Krainer · Bedford, MAExec · Director · PromoterEdward M. Kaye · Bedford, MAExec · DirectorSeth L. Harrison · New York, NYDirectorSamuel W. Hall · Bedford, MADirectorMeena R. Meena · Bedford, MAExecArthur A. Levin · Bedford, MADirectorArthur W. Tzianabos · Bedford, MADirectorIsabel M. Aznarez · Bedford, MAExec · PromoterHuw M. Nash · Bedford, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗